{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T05:24:53Z","timestamp":1783747493050,"version":"3.55.0"},"reference-count":39,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":11,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100003569","name":"Ministry of Food and Drug Safety","doi-asserted-by":"publisher","award":["20173MFDS162F"],"award-info":[{"award-number":["20173MFDS162F"]}],"id":[{"id":"10.13039\/501100003569","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003569","name":"Ministry of Food and Drug Safety","doi-asserted-by":"publisher","award":["23194MFDS086"],"award-info":[{"award-number":["23194MFDS086"]}],"id":[{"id":"10.13039\/501100003569","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004565","name":"Kementerian Pendidikan","doi-asserted-by":"publisher","award":["2021R1A6A1A03044296"],"award-info":[{"award-number":["2021R1A6A1A03044296"]}],"id":[{"id":"10.13039\/501100004565","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["analyticalsciencejournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Separation Science"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    Since the 2018 valsartan recall, the genotoxic impurity\n                    <jats:italic>N\u2010<\/jats:italic>\n                    nitrosodimethylamine (NDMA) has been frequently detected in various pharmaceuticals. Matrix variability often complicates routine testing, requiring customized analyses. We developed a universal LC\u2013MS\/MS method enabling consistent NDMA detection across diverse pharmaceuticals. Separation utilized a C30 column (150\u00a0mm\u00a0\u00d7\u00a04.6 mm I.D., 5 \u00b5m), offering superior retention and shape selectivity for polar nitrosamines compared to conventional reversed phases. Unlike C18 or pentafluorophenyl phases, which often exhibit limited retention for NDMA, the C30 phase provides exceptional shape selectivity and enhanced hydrophobic interactions. This structural advantage, supplemented by its resistance to phase dewetting under highly aqueous conditions further ensures robust resolution between NDMA and complex drug matrices. The mobile phase consisted of 0.1% v\/v formic acid in water and methanol under gradient elution at 1.0 mL\/min. Detection used atmospheric pressure chemical ionization in positive ion mode. The method demonstrated a linear range of 2.0\u2013100.0 ng\/mL (\n                    <jats:italic>r<\/jats:italic>\n                    <jats:sup>2<\/jats:sup>\n                    &gt; 0.999), with a limit of detection of 1.0 ng\/mL and a limit of quantification of 2.0 ng\/mL. Validation per International Council for Harmonisation (ICH) guidelines confirmed accuracy (87.7%\u2013115.5%) and precision (coefficient of variation, CV \u2264 10.7%). Application to 30 diverse pharmaceutical products, including sartans and ranitidine, showed robust resolution (&gt; 2.0) between the analyte and active pharmaceutical ingredients (APIs). Notably, NDMA was quantified in historical batches of ranitidine (164.83 \u00b1 5.68 ng\/mL), nizatidine (10.25 \u00b1 0.52 ng\/mL), and amitriptyline (2.28 \u00b1 0.19 ng\/mL). While the histamine type 2 receptor antagonists significantly exceeded the acceptable daily intake limit, the remaining 27 products showed no detectable NDMA. These findings highlight the method's effectiveness for real\u2010world surveillance and the critical risk of post\u2010manufacturing NDMA generation during prolonged storage. This universal C30\u2010based method provides a practical, reliable tool for routine screening, facilitating regulatory compliance and improved patient safety without drugspecific method development.\n                  <\/jats:p>","DOI":"10.1002\/jssc.70465","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T08:48:00Z","timestamp":1781254080000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A Robust and Universal LC\u2013MS\/MS Method for Determination of\n                    <i>N<\/i>\n                    \u2010Nitrosodimethylamine in Pharmaceuticals Using a C30 Column"],"prefix":"10.1002","volume":"49","author":[{"given":"Byungchan","family":"An","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Analysis College of Pharmacy Chung\u2010Ang University  Dongjak\u2010gu Seoul Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Unyong","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Analysis College of Pharmacy Chung\u2010Ang University  Dongjak\u2010gu Seoul Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumin","family":"Seo","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Analysis College of Pharmacy Chung\u2010Ang University  Dongjak\u2010gu Seoul Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyu","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Analysis College of Pharmacy Chung\u2010Ang University  Dongjak\u2010gu Seoul Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chohee","family":"Jeong","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Analysis College of Pharmacy Chung\u2010Ang University  Dongjak\u2010gu Seoul Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woojin","family":"Jeong","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Analysis College of Pharmacy Chung\u2010Ang University  Dongjak\u2010gu Seoul Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunjin","family":"Ko","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Analysis College of Pharmacy Chung\u2010Ang University  Dongjak\u2010gu Seoul Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhyeon","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Analysis College of Pharmacy Chung\u2010Ang University  Dongjak\u2010gu Seoul Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun\u2010Deok","family":"Cho","sequence":"additional","affiliation":[{"name":"Division of Non\u2010Clinic Studies Korea Institute of Toxicology  Daejeon Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Beom","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Analysis College of Pharmacy Chung\u2010Ang University  Dongjak\u2010gu Seoul Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2018.11.010"},{"key":"e_1_2_11_3_1","unstructured":"USFDA \u201cControl of Nitrosamine Impurities in Human Drugs\u201d2024 https:\/\/www.fda.gov\/regulatory\u2010information\/search\u2010fda\u2010guidance\u2010documents\/control\u2010nitrosamine\u2010impurities\u2010human\u2010drugs."},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2020.121659"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598\u2010019\u201048344\u20105"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2020.113460"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2021.04.021"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.oprd.3c00473"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.oprd.3c00153"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2020.113877"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1248\/cpb.c20\u201000431"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrestox.4c00234"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.23049\/FDCRS.2021.16.1.063"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2021.106026"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1080\/10408347.2020.1788375"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10010153"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598\u2010020\u201062149\u2010x"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1080\/16583655.2023.2254352"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.38212\/2224\u20106614.1133"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2019.05.022"},{"key":"e_1_2_11_21_1","unstructured":"ICH \u201cICH Q2(R2) Guideline on Validation of Analytical Procedure \u201d2023 https:\/\/database.ich.org\/sites\/default\/files\/ICH_Q2(R2)_Guideline_2023_1130.pdf."},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.2175\/106143004X141906"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2022.158275"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.aca.2020.05.007"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.22037\/ijpr.2021.115222.15258"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021\u20109673(01)94410\u20103"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021\u20109673(01)81519\u20103"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcoa.2022.100037"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00216\u2010004\u20102858\u20109"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10337\u2010015\u20102899\u20106"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1021\/ac970414j"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trac.2018.09.003"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10337\u2010022\u201004137\u2010z"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chroma.2015.02.023"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1021\/ac020361s"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1044\u20100305(03)00574\u20109"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021\u20109673(99)00898\u20105"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1021\/jasms.2c00034"},{"key":"e_1_2_11_39_1","unstructured":"USFDA \u201cLiquid Chromatography\u2010High Resolution Mass Spectrometry (LC\u2010HRMS) Method for the Determination of Six Nitrosamine Impurities in ARB Drugs\u201d2019 https:\/\/www.fda.gov\/media\/125478\/download."},{"key":"e_1_2_11_40_1","unstructured":"USFDA \u201cLiquid Chromatography\u2010Tandem Mass Spectrometry (LC\u2010MS\/MS) Method for the Determination of NDMA in Ranitidine Drug Substance and Solid Dosage Drug Product\u201d2019 https:\/\/www.fda.gov\/media\/131868\/download."}],"container-title":["Journal of Separation Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jssc.70465","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jssc.70465","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jssc.70465","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T12:50:44Z","timestamp":1782996644000},"score":1,"resource":{"primary":{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/10.1002\/jssc.70465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.1002\/jssc.70465"],"URL":"https:\/\/doi.org\/10.1002\/jssc.70465","archive":["Portico"],"relation":{},"ISSN":["1615-9306","1615-9314"],"issn-type":[{"value":"1615-9306","type":"print"},{"value":"1615-9314","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"2026-01-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70465"}}